Who Owns ACADIA Pharmaceuticals Stock?
NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 98.25%
- Held by insiders
- 0.73%
- Institutional holders
- 471
- Institutions 98.3%
- Insiders 0.7%
- Public and other 1.0%
Who owns ACADIA Pharmaceuticals stock?
Institutional investors own about 98.3% of ACADIA Pharmaceuticals's shares, spread across 471 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.73% of ACAD.
The largest institutional holders are Baker Bros. Advisors, LP (24.83%), Blackrock Inc. (13.03%) and Vanguard Portfolio Management LLC (5.11%). Together, the top 10 institutions control 61.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ACAD positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ACAD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Baker Bros. Advisors, LP | 42.91M | 24.83% | +0.0% |
| Blackrock Inc. | 22.52M | 13.03% | +4.5% |
| Vanguard Portfolio Management LLC | 8.84M | 5.11% | +1.9% |
| State Street Corporation | 7.65M | 4.43% | -15.7% |
| RTW Investments LP | 7.14M | 4.13% | 0.0% |
| Vanguard Capital Management LLC | 5.76M | 3.33% | +1.8% |
| Geode Capital Management, LLC | 3.37M | 1.95% | +0.4% |
| Dimensional Fund Advisors LP | 3.37M | 1.95% | -8.9% |
| Palo Alto Investors Lp | 2.86M | 1.66% | -0.3% |
| Goldman Sachs Group Inc | 2.58M | 1.49% | +65.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ACAD
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 7.69M | 4.45% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.07M | 2.36% |
| iShares Trust-iShares Russell 2000 ETF | 3.33M | 1.93% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.95M | 1.71% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.47M | 1.43% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.70M | 0.98% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.46M | 0.84% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.41M | 0.82% |
| iShares Trust-iShares Biotechnology ETF | 1.33M | 0.77% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.21M | 0.70% |
Frequently asked questions
Who is the largest shareholder of ACADIA Pharmaceuticals?
Baker Bros. Advisors, LP is the largest institutional shareholder of ACAD, owning 24.83% of shares outstanding (42.91M shares) as of its latest 13F filing.
What percentage of ACADIA Pharmaceuticals is owned by institutions?
Institutions own about 98.3% of ACAD shares and 99.0% of the public float.
How much of ACADIA Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.73% of ACAD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.